Drug companies reveal GP payments

GPs and other specialists face fresh scrutiny as drug companies begin detailing how much they pay in return for advice on their medicines.

Some 376 unnamed health professionals received $600,000 in honoraria — an average fee of $1600 each — for attending meetings to advise companies between January and March this year.

Details of expenditure for advisory board meetings were made public for the first time on the website for